| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 11/25/1999 | WO1999059975A1 Fused tricyclic compounds which inhibit parp activity |
| 11/25/1999 | WO1999059971A1 Novel 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 11/25/1999 | WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION |
| 11/25/1999 | WO1999059964A1 Novel analogs of 16-hydroxyeicosatetraenoic acid |
| 11/25/1999 | WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 11/25/1999 | WO1999059811A1 Multi-action particle for structuring biological media |
| 11/25/1999 | WO1999059623A1 Methods and means for preventing or treating inflammation or pruritis |
| 11/25/1999 | WO1999059620A1 Angiostatin receptor |
| 11/25/1999 | WO1999059610A2 Use of lipopeptides or lipoproteins for wound treatment |
| 11/25/1999 | WO1999059540A1 Antimicrobial agent |
| 11/25/1999 | WO1999059538A1 Topical composition |
| 11/25/1999 | WO1999047545A3 Inhibitors of caspases |
| 11/25/1999 | WO1999047517A8 Novel heterocyclic compounds |
| 11/25/1999 | WO1999043787A3 A living chimeric skin replacement |
| 11/25/1999 | WO1999043344A3 Matrix protein compositions for wound healing |
| 11/25/1999 | DE19922287A1 Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters |
| 11/25/1999 | DE19822820A1 Wound healing composition comprising lipopeptide or lipoprotein that stimulates leukocyte infiltration |
| 11/25/1999 | DE19821971A1 Composition for treating psoriasis or neurodermatitis |
| 11/25/1999 | CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation |
| 11/25/1999 | CA2332803A1 Multi-action particle for structuring biological media |
| 11/25/1999 | CA2332709A1 Antimicrobial agent |
| 11/25/1999 | CA2332507A1 Angiostatin receptor |
| 11/25/1999 | CA2332500A1 Topical composition |
| 11/25/1999 | CA2332272A1 Novel analogs of 16-hydroxyeicosatetraenoic acid |
| 11/25/1999 | CA2332239A1 Fused tricyclic compounds which inhibit parp activity |
| 11/25/1999 | CA2328489A1 Secreted proteins and polynucleotides encoding them |
| 11/25/1999 | CA2272833A1 Novel histidine derivatives, process for its preparation and uses thereof |
| 11/24/1999 | EP0959069A1 A process for the preparation of 13-CIS-retinoic acid |
| 11/24/1999 | EP0958833A1 Methods and means for preventing or treating inflammation |
| 11/24/1999 | EP0958823A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 11/24/1999 | EP0958814A1 Patch having a thermal effect and its use |
| 11/24/1999 | EP0958810A2 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 11/24/1999 | EP0958807A1 Low water no volatile organic compound hair lightener and dyeing composition |
| 11/24/1999 | EP0958366A1 Human chemokine beta-13 |
| 11/24/1999 | EP0958362A1 Isolation and use of motoneuronotrophic factors |
| 11/24/1999 | EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 11/24/1999 | EP0957907A1 Il-8 receptor antagonists |
| 11/24/1999 | EP0957898A1 Personal wash liquid composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 11/24/1999 | EP0957887A2 Composition and method for reducing stinging in skin |
| 11/24/1999 | EP0892632A4 Compositions useful in the phototherapeutic treatment of proliferative skin disorders |
| 11/24/1999 | EP0662836B1 Germicidal detergent-iodine compositions having reduced detergent content |
| 11/24/1999 | EP0650366B1 Compositions and methods for treating wounds |
| 11/24/1999 | CN1236367A Benzonaphthyrindines as bronchial therapeutics |
| 11/24/1999 | CN1236359A Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same |
| 11/24/1999 | CN1236354A Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same |
| 11/24/1999 | CN1235839A Chinese and Western medicinal preparation for curing hand and foot tinea |
| 11/24/1999 | CN1235837A Psoriasis paster |
| 11/24/1999 | CN1046731C Pyrrolo [2,3-d] pyrimidines and their use |
| 11/23/1999 | US5990329 Retinoids |
| 11/23/1999 | US5990314 Pharmaceutical pyridine compounds |
| 11/23/1999 | US5990142 Antiinflammatory agents and antiallergens having good oral adsorption and bioavailability; cardiotonic and antiischemic agents |
| 11/23/1999 | US5990116 Trisubstituted phenyl derivatives |
| 11/23/1999 | US5990109 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 11/23/1999 | US5990103 Treating psoriasis by topical adminstration of pentoxifylline and diltiazem to a patient; a combination of a compound having a phosphodiesterase-inhibiting action, and a compound which reduces the intracellular calcium content |
| 11/23/1999 | US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus |
| 11/23/1999 | US5989596 Applying composition containing a sulfite and a plant extract |
| 11/23/1999 | US5989577 Nontoxic vernix compositions and method of producing |
| 11/23/1999 | US5989559 Banana peel extract composition and method for extraction |
| 11/23/1999 | US5989558 Extracting leaves with aqueous ethanol |
| 11/23/1999 | CA2154898C Stable sulfide compositions, uses, and process for preparation thereof |
| 11/23/1999 | CA2015919C Cleaning compositions |
| 11/23/1999 | CA1340825C Hyaluronic acid fraction for use as a drug delivery system for medicaments |
| 11/18/1999 | WO1999058642A2 Secreted proteins and polynucleotides encoding them |
| 11/18/1999 | WO1999058555A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
| 11/18/1999 | WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 11/18/1999 | WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 11/18/1999 | WO1999058505A2 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 11/18/1999 | WO1999058502A1 Heterocyclic inhibitors of p38 |
| 11/18/1999 | WO1999058104A1 Therapeutic compositions |
| 11/18/1999 | WO1999058096A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 11/18/1999 | WO1999058000A1 Nutritional composition for the treatment of pressure ulcers |
| 11/18/1999 | WO1999050239A3 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same |
| 11/18/1999 | WO1999049856A3 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 11/18/1999 | WO1999049855A3 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils |
| 11/18/1999 | WO1999046364A9 Vascular endothelial growth factor 2 |
| 11/18/1999 | WO1999045933A9 Novel delivery of hydroxy carboxylic acids |
| 11/18/1999 | WO1999027098A3 A-33 related antigens and their pharmacological uses |
| 11/18/1999 | CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors |
| 11/18/1999 | CA2331501A1 Therapeutic compositions |
| 11/18/1999 | CA2331371A1 Water-soluble pro-drugs of propofol |
| 11/18/1999 | CA2331295A1 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 11/18/1999 | CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 11/18/1999 | CA2328062A1 Secreted proteins and polynucleotides encoding them |
| 11/17/1999 | EP0956869A2 Tissue sealant |
| 11/17/1999 | EP0956864A1 Tissue fibrosis inhibitor |
| 11/17/1999 | EP0956852A2 Skin external preparation |
| 11/17/1999 | EP0956851A1 Use of nanotopes in cosmetic products |
| 11/17/1999 | EP0956299A1 Peptide antagonists of dp transcription factors |
| 11/17/1999 | EP0956048A1 Stable compositions containing biologically active components |
| 11/17/1999 | EP0956042A2 Mycosis vaccines |
| 11/17/1999 | EP0956034A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
| 11/17/1999 | EP0956030A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 11/17/1999 | EP0956016A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 11/17/1999 | EP0955996A1 Skin care compositions containing an amide and a retinoid |
| 11/17/1999 | EP0955995A1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
| 11/17/1999 | EP0955993A1 Topical composition and method for enhancing lipid barrier synthesis |
| 11/17/1999 | CN1235609A Immunostimulatory nucleic acid molecules |
| 11/17/1999 | CN1235603A N-substituted azaheterocyclic compounds |
| 11/17/1999 | CN1235550A Synergistic gold-containing compositions |
| 11/17/1999 | CN1235045A Medicinal composite for acne and preparing method thereof |